Growing up in a bubble: using germ-free animals to assess the influence of the gut microbiota on brain and behavior by Luczynski, Pauline et al.
Title Growing up in a bubble: using germ-free animals to assess the influence
of the gut microbiota on brain and behavior
Author(s) Luczynski, Pauline; McVey Neufeld, Karen-Anne; Oriach, Clara Seira;
Clarke, Gerard; Dinan, Timothy G.; Cryan, John F.
Publication date 2016-02-23
Original citation LUCZYNSKI, P., MCVEY NEUFELD, K.-A., ORIACH, C. S.,
CLARKE, G., DINAN, T. G. and CRYAN, J. F. (2016) ‘Growing up in
a bubble: using germ-free animals to assess the influence of the gut
microbiota on brain and behavior’, International Journal of
Neuropsychopharmacology, 19(8), pp. 1-17. doi:10.1093/ijnp/pyw020
Type of publication Article (peer-reviewed)
Link to publisher's
version
http://dx.doi.org/10.1093/ijnp/pyw020
Access to the full text of the published version may require a
subscription.
Rights © 2016, the Authors. This is an Open Access article distributed
under the terms of the Creative Commons Attribution Non-
Commercial License (http://creativecommons.org/licenses/by-
nc/4.0/), which permits non-commercial re-use, distribution, and
reproduction in any medium, provided the original work is properly
cited.
http://creativecommons.org/licenses/by-nc/4.0/
Item downloaded
from
http://hdl.handle.net/10468/3269
Downloaded on 2018-08-23T17:57:33Z
Received: December 10, 2015; Revised: February 15, 2016; Accepted: February 18, 2016
© The Author 2016. Published by Oxford University Press on behalf of CINP.
International Journal of Neuropsychopharmacology, (2016) 19(8): 1–17
doi:10.1093/ijnp/pyw020
Advance Access Publication: February 23, 2016
Review
1
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, 
provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
review
Growing up in a Bubble: Using Germ-Free Animals to 
Assess the Influence of the Gut Microbiota on Brain 
and Behavior
Pauline Luczynski, MSc; Karen-Anne McVey Neufeld, PhD; Clara Seira Oriach, MSc; 
Gerard Clarke, PhD; Timothy G. Dinan, MD, PhD, DSc; John F. Cryan, PhD
APC Microbiome Institute (Ms Luczynski, Dr McVey Neufeld, Ms Oriach, Dr Clarke, Dr Dinan, and Dr Cryan), 
Department of Psychiatry and Neurobehavioral Science (Ms Oriach, Dr Clarke, and Dr Dinan), and Department 
of Anatomy and Neuroscience (Dr Cryan), University College Cork, Cork, Ireland.
Correspondence: John F. Cryan, PhD, Room 3.86, Western Gateway Building, University College Cork, Cork, Ireland (J.Cryan@ucc.ie).
Abstract
There is a growing recognition of the importance of the commensal intestinal microbiota in the development and later 
function of the central nervous system. Research using germ-free mice (mice raised without any exposure to microorganisms) 
has provided some of the most persuasive evidence for a role of these bacteria in gut-brain signalling. Key findings show that 
the microbiota is necessary for normal stress responsivity, anxiety-like behaviors, sociability, and cognition. Furthermore, the 
microbiota maintains central nervous system homeostasis by regulating immune function and blood brain barrier integrity. 
Studies have also found that the gut microbiota influences neurotransmitter, synaptic, and neurotrophic signalling systems 
and neurogenesis. The principle advantage of the germ-free mouse model is in proof-of-principle studies and that a complete 
microbiota or defined consortiums of bacteria can be introduced at various developmental time points. However, a germ-free 
upbringing can induce permanent neurodevelopmental deficits that may deem the model unsuitable for specific scientific 
queries that do not involve early-life microbial deficiency. As such, alternatives and complementary strategies to the germ-
free model are warranted and include antibiotic treatment to create microbiota-deficient animals at distinct time points 
across the lifespan. Increasing our understanding of the impact of the gut microbiota on brain and behavior has the potential 
to inform novel management strategies for stress-related gastrointestinal and neuropsychiatric disorders.
Keywords: microbiota-gut-brain axis, germ-free mouse, stress response, social development, cognitive dysfunction
Introduction
Medicine is magical and magical is art
Thinking of the Boy in the Bubble
“Boy in the Bubble” by Paul Simon, 1986
Humans and other animals share an inextricable and mutualis-
tic relationship with a myriad of resident microorganisms, col-
lectively known as the microbiota. These microbial species are 
present on all body surfaces, including the gastrointestinal (GI) 
tract, respiratory tract, skin, and urogenital tract (Costello et al., 
2009). Research on the interactions between microorganisms 
and their host has largely and understandably been focused 
on those residing in the intestinal lumen, given that this is the 
most densely colonized and home to approximately 100 trillion 
bacteria (Frank and Pace, 2008). Over the last decade, numerous 
scientific discoveries have highlighted the role of the microbiota 
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in critical processes, including digestion (Hooper and Gordon, 
2001), immune responses (Bäckhed et  al., 2005; Hooper and 
Macpherson, 2010), absorption of nutrients (Hooper and Gordon, 
2001), growth (Nicholson et al., 2012), and metabolism (Tremaroli 
and Backhed, 2012). Until recently, little was known about the role 
of the microbiota in the regulation of the central nervous sys-
tem (CNS); however, there is now a burgeoning body of evidence 
indicating that the gut microbiota also influences the brain and 
behavior (Rhee et al., 2009; Collins et al., 2012; Cryan and Dinan, 
2012; Dinan and Cryan, 2012; Dinan et al., 2013; Foster and McVey 
Neufeld, 2013; Foster et  al., 2015; Sampson and Mazmanian, 
2015). These fascinating insights have largely been derived from 
the study of germ-free (GF) animals that effectively grow up in a 
sterile bubble and have provided conceptual impetus to the pos-
sibility of exploiting the gut microbiota as a therapeutic target.
The Microbiota-Gut-Brain Axis
The concept of the gut-brain axis has been recognized for some 
time and has been used as a framework to assess mechanisms 
by which bidirectional communication between these 2 systems 
occurs. More recently, this axis has been extended to include 
the contents of the intestinal lumen, and we now refer to the 
existence of a ‘microbiota-gut-brain axis’ (Rhee et  al., 2009; 
Bercik, 2011; Cryan and O’Mahony, 2011; Cryan and Dinan, 2012; 
Burokas et al., 2015; Mayer et al., 2015), highlighting the increas-
ingly appreciated importance of bacteria in this communication 
highway. While the necessity of commensal intestinal micro-
biota for the maintenance of optimal gut-brain function is no 
longer disputed, the exact mechanisms by which microbiota-
gut-brain communication occurs are still largely unknown. It is 
probable that a number of systems are simultaneously involved 
in the transmission of information between microbiota and 
brain, and research has focused primarily on immune, neural, 
endocrine, and metabolic pathways as likely mediators in this 
bidirectional communication (Cryan and Dinan, 2012; Foster and 
McVey Neufeld, 2013; El Aidy et al., 2015; Janssen and Kersten, 
2015; Mayer et al., 2015).
The human gut is extensively innervated, with approxi-
mately 50 000 extrinsic and 100 million intrinsic sensory affer-
ent neurons (Furness, 2006; Blackshaw et al., 2007), all of which 
function in proximity to the trillions of microorganisms housed 
in the intestinal lumen. It is thus unsurprising that neural path-
ways play a vital role in microbiota-gut-brain communication. 
The necessity of an intact vagal nerve for information regard-
ing intestinal microbial status seems dependent upon the spe-
cific bacterial species in question, and while some studies have 
shown the vagus is vital for information transfer (Lyte et  al., 
2006; Bercik et al., 2011b; Bravo et al., 2011), others have found 
evidence of vagal independence (Bercik et  al., 2010, 2011a). 
Intrinsic primary afferent neurons housed within the gut wall 
have also been shown to be responsive to changes in intestinal 
bacterial status (Kunze et al., 2009; Mcvey Neufeld et al., 2013).
Similarly, while rodent infection studies using subclinical 
doses of pathogenic bacteria have indicated that immune sys-
tem activation is not always necessary to observe changes in 
brain neurochemistry and behavior (Lyte et  al., 2006), there is 
clear evidence of the importance of an intact and functioning 
immune system in gut-brain communication (Macpherson and 
Harris, 2004; Bengmark, 2013; El Aidy et al., 2015).
The endocrine system too plays a role in the ability of bacte-
ria to alter brain functioning (Lyte, 2013), and many studies have 
now demonstrated changes in endocrine signalling in mod-
els of intestinal dysbiosis (Sudo et al., 2004; Bercik and Collins, 
2014) and also the ability to alter intestinal microbial contents 
following hypothalamic-pituitary-adrenal (HPA) axis activation 
(O’Mahony et al., 2009; De Palma et al., 2015; Golubeva et al., 2015).
The Microbiota in Health and Disease
Compelling clinical evidence exists supporting the view that a 
stable and diverse gut microbial composition is important for the 
maintenance of optimal health. Indeed, altered microbial profiles 
have been associated with numerous human illnesses, includ-
ing cardiovascular disease (Koren et al., 2011; Howitt and Garrett, 
2012; Karlsson et al., 2012; Tuohy et al., 2014; Hansen et al., 2015), 
irritable bowel syndrome (IBS) (Salonen et al., 2010; Tana et al., 
2010; Jeffery et al., 2012; Wu, 2012), inflammatory bowel disease 
(Ananthakrishnan, 2015; Marchesi et  al., 2015; Sheehan et  al., 
2015), obesity (Ley et al., 2006; Turnbaugh et al., 2009a; Tremaroli 
and Backhed, 2012), and type 2 diabetes (Qin et al., 2012; Vrieze 
et al., 2012; Karlsson et al., 2013). However, there is presently lit-
tle data detailing a clear link between the gut microbiota and 
the clinical manifestation of CNS diseases, although mounting 
preclinical evidence highlights the necessity for such studies.
The impact of the microbiota on the CNS can be investigated 
by assessing behavior following various deliberate interven-
tions. Infection with pathogenic bacteria heightens anxiety-like 
behavior and reduces cognitive abilities (Lyte et al., 1998, 2006; 
Goehler et  al., 2008; Gareau et  al., 2011). Similarly, antibiotic 
administration alters the gut microbial composition, which is 
accompanied by reduced anxiety-like behavior (Bercik et  al., 
2011a). Probiotics, live organisms that provide health benefits 
when consumed, improve cognition and attenuate heightened 
stress responsivity in both humans and rodents (Bravo et  al., 
2011; Messaoudi et al., 2011; Savignac et al., 2015). As such, we 
have recently coined the term “psychobiotic” to describe bacte-
ria with beneficial effects on mental health (Dinan et al., 2013). 
Finally, behavioral traits such as anxiety can be transferred via 
fecal transplantation (Bercik et al., 2011a), although this field of 
research is still in its early stages.
Research using GF mice has arguably provided the most con-
vincing evidence for a role of the microbiota in gut-brain signal-
ling. GF studies have generated exciting data with the goal of 
directly answering the question: does the gut microbiota influ-
ence the nervous system? This review will summarize what the 
GF mouse model has revealed about the importance of the gut 
microbiota on the development and function of the CNS with 
a focus on neuropsychiatric disorders. Tables 1 and 2 detail 
what we currently know about how growing up in the absence 
of microorganisms alters behavior and brain function, respec-
tively. In this review, we focus on the GF mouse, but it is worth 
noting that GF rats, pigs, flies, and fish have also been studied 
(Gordon and Wostmann, 1960; Gordon and Pesti, 1971; Luckey, 
2012; Crumeyrolle-Arias et al., 2014; Wang and Donovan, 2015). GF 
mice are a powerful scientific tool allowing researchers to directly 
study the influence of the microbiota on CNS function and devel-
opment. One of the main advantages to this model is that identi-
fied strains of bacteria, such as candidate psychobiotics, can be 
introduced into GF animals and their effects studied in isola-
tion from other microbes. Furthermore, the gut microbiota of GF 
mice can be “humanized” by transplanting fecal microbiota from 
human patients or alternatively inoculated from animal mod-
els of disease (Turnbaugh et al., 2006, 2009b; Bercik et al., 2011a; 
Borody and Khoruts, 2012; Cryan and Dinan, 2012; Aroniadis and 
Brandt, 2013; Ridaura et al., 2013; Suez et al., 2014; Thaiss et al., 
2014; Leone et al., 2015), thus enabling the study of the role of 
given combinations of bacteria on disease pathogenesis.
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Germ-Free Life: Past and Present
A common approach used to gauge the key functions of an 
organ or brain structure involves abolishing its contribution 
either surgically or by other means. For example, the func-
tion of a brain region can be determined by studying the defi-
cits that follow lesioning the area in question. It was therefore 
not surprising for biologists studying the effects of bacteria on 
health and disease to ask how the host would be affected by 
the absence of microbiota. To help answer this question, GF ani-
mals were generated.
Historically, the concept of gnotobiosis, where all forms of 
life present within an organism are known, can be attributed to 
Louis Pasteur. In 1885, he speculated that animals lacking bac-
teria would not be able to survive because of the close synergis-
tic evolution of microbes and their hosts (Pasteur, 1885; Gordon 
and Pesti, 1971). After the Second World War, and following the 
advent of antibiotics, a life without microbes became a popular 
topic of discussion (Kirk, 2012). By the 1960s, GF life was promi-
nently featured in medical, scientific, and popular press, often 
represented as the futuristic mixture of fact and fiction. In the 
early years of space exploration, scientists recognized that extra-
terrestrial ventures could introduce terrestrial microorganisms 
to space and, conversely, extraterrestrial microorganisms to 
earth with potentially devastating outcomes (Wolfe, 2002; Kirk, 
2012). It was thus suggested that GF men may be necessary to 
explore space. This idea entered public awareness with Michael 
Crichton’s The Andromeda Strain, which narrated a fictional battle 
against a deadly extraterrestrial pathogen introduced to earth as 
a result of man’s travels in space (Crichton, 1993). Life without 
microbes has continued to garner interest in popular culture, 
perhaps most notably with David Vetter, a patient with severe 
combined immunodeficiency who was raised isolated in ster-
ile conditions and became known as the Bubble Boy (Lawrence, 
1985; Kirk, 2012).
The first GF animals, guinea pigs, were generated by asep-
tic caesarean section at the end of the nineteenth century 
and kept GF for 2 weeks (Nuttall and Thierfelder, 1897). GF 
research programs developed independently at 3 different 
institutions, definitively proving that life is possible, albeit not 
desirable, without microbes. In the mid-twentieth century, 
a group headed by James Reyniers at the University of Notre 
Dame was the first to rear successive generations of GF rodents 
(Reyniers et  al., 1946; Reyniers, 1959). Around the same time, 
Bengt Gustafsson at the University of Lund in Sweden also 
generated GF animals with a novel rearing isolator system 
(Gustaffson et  al., 1957; Gustafsson, 1959a). A  third GF pro-
gram later began at the University of Nagoya led by Masasumi 
Table 1. The Germ-Free Behavioral Profile
Parameter Phenotype Strain and Sex Test Reversible? Reference
Anxiety-like behavior Decreased anxiety-like 
behavior
Swiss Webster (m) OF Arentsen et al., 2015
No change in anxiety-like 
behavior
Swiss Webster (m)
BALB/c (m)
SD Bercik et al., 2011a
Decreased anxiety-like 
behavior
Swiss Webster (m) LDB Yes Clarke et al., 2013
Increased anxiety like 
behavior
F344 rat (m) OF Crumeyrolle-Arias 
et al., 2014
Altered anxiety-like 
behavior
C57BL/6N (m & f) LD: decreased anxiety
SD: increased anxiety
De Palma et al., 2015
No change in anxiety-like 
behavior
Swiss Webster (f) LDB Gareau et al., 2011
Decreased anxiety-like 
behavior
NMRI (m) OF, LDB, EPM Yes: EPM
No: LDB, OF
Heijtz et al., 2011
Decreased anxiety-like 
behavior
Swiss Webster (f) EPM Neufeld et al., 2011
Learning & memory No change in olfactory 
memory
Swiss Webster (m) STFP Desbonnet et al., 2014
Impaired short-term 
recognition and working 
memory
Swiss Webster (f) NOR, TM Gareau et al., 2011
Locomotor behavior Increased locomotor and 
rearing behaviors
NMRI (m) OF Yes Heijtz et al., 2011
No change in locomotor 
activity
Swiss Webster (f) – Neufeld et al., 2011
Self-grooming Increased self-grooming 
time
Swiss Webster (m) – Desbonnet et al., 2014
Social cognition No preference for novel vs 
familiar mouse
Swiss Webster (m>f) TCS Yes Desbonnet et al., 2014
Social preference Increased social interaction 
with conspecific
Swiss Webster (m) TCS Arentsen et al., 2015
Social avoidance of 
conspecific
Swiss Webster (m>f) TCS No Desbonnet et al., 2014
Abbreviations: EPM, elevated plus maze; f, female; LDB, light-dark box; m, male; m>f, phenotype expressed more strongly in males than females; NOR, novel object 
recognition test; OF, open field test; SD, step-down test; STFP, social transmission of food preference test; TM, T-maze; TCS, 3-chambered sociability test.
Summary of the behavioral profile of GF mice. Experiments which are reversible or irreversible with bacterial colonization are indicated with ‘Yes’ or ‘No,’ respec-
tively.
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Miyakawa (Miyakawa, 1959). GF technology was applied to vari-
ous other fields. For example, GF techniques were utilized in the 
maternity ward, the general hospital, and the operating theater 
to prevent cross-infection (Reyniers, 1942, 1943; Kirk, 2012). In 
industrialized farming, GF animals were reared to create herds 
free of pathogens that slow livestock growth and to aid in vet-
erinary practices (Betts and Trexler, 1969; Kirk, 2012). Perhaps 
most notoriously, GF technology was used to protect immu-
nocompromised newborns, creating GF humans (Barnes et al., 
1968, 1969a, 1969b; Lawrence, 1985; Kirk, 2012). However, despite 
GF technology’s numerous uses, it has failed to become widely 
implemented outside of the laboratory.
The current methodology underlying the generation of 
GF animals remains largely unchanged since it was first pio-
neered by Reyniers. To generate the initial GF colony, pups are 
carefully delivered via Caesarean section to avoid contamina-
tion with the microbes living on the mother’s vagina and skin 
(Gustafsson, 1959a; Reyniers, 1959; Macpherson and Harris, 
2004; Smith et al., 2007; Faith et al., 2010; Bibiloni, 2012; Stilling 
et al., 2014b). Newly born animals are then hand-reared in an 
aseptic isolator. Subsequent generations of GF animals can be 
obtained through a much simpler process: GF mice are inter-
bred and mothers can give birth naturally in the isolator with-
out exposing the new litter to any microorganisms (Gustafsson, 
1959a; Reyniers, 1959; Macpherson and Harris, 2004; Smith 
et al., 2007; Faith et al., 2010). Most commercially available GF 
animals generated in this way can be shipped in a sterile con-
tainer for transfer to local GF facilities. An alternative method 
involves the transfer of an embryo at the 2-cell stage into a 
pseudo-pregnant GF mother (Smith et  al., 2007; Faith et  al., 
2010; Bibiloni, 2012). Colonies are maintained in aseptic isola-
tors in a GF unit where the food, water, and bedding are sterile. 
A technician swabs the cages and analyzes fecal samples using 
bacterial culture techniques weekly to confirm that the GF unit 
is indeed sterile (Bibiloni, 2012; Williams, 2014). These meth-
ods make certain that GF mice never come into contact with 
any bacteria, not only in their gut but also on any other body 
surface. It is worth noting the logistical difficulties that limit 
the study of GF mice: conduction of complex interventions and 
behavioral assessments must be performed in the isolator unit 
if these animals are to remain free of microbes. To avoid these 
limitations, most GF studies are often executed shortly after the 
animals are removed from isolation, before bacterial coloniza-
tion can have an effect.
The Germ-Free Mouse and Health
The extent to which Pasteur was correct in his assertions of 
the importance of the microbiota for an organism’s health is 
now clear; GF animals are functionally and structurally abnor-
mal across numerous body systems. GF research has revealed 
that the microbiota is necessary for normal aging and immune, 
metabolic, digestive, GI, and nervous system function (Grenham 
et al., 2011).
Aging
There is growing evidence indicating that the gut microbi-
ota influences the aging process. Indeed, GF mice live longer 
than conventionally colonized control animals (Reyniers and 
Sacksteder, 1958; Gordon et  al., 1966; Tazume et  al., 1991). As 
GF mice are raised in sterile conditions, their longer life span is 
likely due to the absence of pathological infections. In humans, 
microbial diversity and stability decrease with age and are 
accompanied by cognitive decline (O’Toole and Claesson, 2010; C
at
eg
or
y
Pa
ra
m
et
er
Ph
en
ot
yp
e
S
tr
ai
n
 a
n
d
 S
ex
T
is
su
e/
B
ra
in
 R
eg
io
n
R
ev
er
si
b
le
?
R
ef
er
en
ce
St
re
ss
 h
or
m
on
e 
 
si
gn
al
li
n
g
A
C
T
H
In
cr
ea
se
d
 A
C
T
H
 a
ft
er
 1
 h
ou
r 
of
 
re
st
ra
in
t 
st
re
ss
B
A
LB
/c
 (m
)
B
lo
od
: p
la
sm
a
Y
es
Su
d
o 
et
 a
l.,
 2
00
4
C
or
ti
co
st
er
on
e
In
cr
ea
se
d
 c
or
ti
co
st
er
on
e 
af
te
r 
30
 
m
in
u
te
s 
of
 s
tr
es
s
Sw
is
s 
W
eb
st
er
  
(m
, f
)
B
lo
od
: p
la
sm
a
C
la
rk
e 
et
 a
l.,
 2
01
3
C
or
ti
co
st
er
on
e
In
cr
ea
se
d
 c
or
ti
co
st
er
on
e 
af
te
r 
op
en
 
fi
el
d
 s
tr
es
s
F3
44
 r
at
 (m
)
B
lo
od
: s
er
u
m
C
ru
m
ey
ro
ll
e-
A
ri
as
 
et
 a
l.,
 2
01
4
C
or
ti
co
st
er
on
e
In
cr
ea
se
d
 b
as
al
 c
or
ti
co
st
er
on
e
Sw
is
s 
W
eb
st
er
 (f
)
B
lo
od
: p
la
sm
a
N
eu
fe
ld
 e
t 
al
., 
20
11
C
or
ti
co
st
er
on
e
In
cr
ea
se
d
 c
or
ti
co
st
er
on
e 
af
te
r 
1 
h
ou
r 
of
 r
es
tr
ai
n
t 
st
re
ss
B
A
LB
/c
 (m
)
B
lo
od
: p
la
sm
a
Y
es
Su
d
o 
et
 a
l.,
 2
00
4
G
lu
co
co
rt
ic
oi
d
 r
ec
ep
to
r
D
ec
re
as
ed
 g
lu
co
co
rt
ic
oi
d
 m
R
N
A
 
ex
p
re
ss
io
n
B
A
LB
/c
 (m
)
C
or
te
x
Su
d
o 
et
 a
l.,
 2
00
4
A
bb
re
vi
at
io
n
s:
 A
C
T
H
, a
d
re
n
oc
or
ti
co
tr
op
ic
 h
or
m
on
e;
 B
D
N
F,
 b
ra
in
-d
er
iv
ed
 n
eu
ro
tr
op
h
ic
 f
ac
to
r;
 E
A
E,
 e
xp
er
im
en
ta
l a
u
to
im
m
u
n
e 
en
ce
p
h
al
om
ye
li
ti
s;
 N
G
FI
-A
, n
er
ve
 g
ro
w
th
 f
ac
to
r-
in
d
u
ci
bl
e 
cl
on
e;
 P
SD
-9
5,
 p
os
t-
sy
n
ap
ti
c 
d
en
si
ty
 
p
ro
te
in
 9
5.
Su
m
m
ar
y 
of
 t
h
e 
m
ol
ec
u
la
r 
an
d
 c
el
lu
la
r 
p
ro
fi
le
 o
f 
G
F 
m
ic
e.
 E
xp
er
im
en
ts
 w
h
ic
h
 a
re
 r
ev
er
si
bl
e 
or
 ir
re
ve
rs
ib
le
 w
it
h
 b
ac
te
ri
al
 c
ol
on
iz
at
io
n
 a
re
 in
d
ic
at
ed
 w
it
h
 ‘Y
es
’ o
r 
‘N
o,
’ r
es
p
ec
ti
ve
ly
.
Ta
b
le
 2
. 
C
on
ti
nu
ed
 by guest on O
ctober 14, 2016
http://ijnp.oxfordjournals.org/
D
ow
nloaded from
 
6 | International Journal of Neuropsychopharmacology, 2016
Borre et al., 2014). These findings have prompted the idea that 
restoring microbial diversity in the elderly could improve gen-
eral and mental health.
Immune and Gastrointestinal Function
The gut microbiota is necessary for the normal function of the 
mucosal immune system. Toll-like receptors (TLRs) recognize 
pathogen-associated molecular patterns in the gut, differentiating 
pathogenic bacteria from harmless commensal microorganisms 
(Akira and Hemmi, 2003). GF animals have decreased or absent 
expression of certain TLRs, reduced IgA secretion, and fewer 
and smaller Peyer’s patches, which are the lymphoid follicles in 
the intestinal wall (Abrams et  al., 1962; Wostmann et  al., 1970; 
Shanahan, 2002; Grenham et al., 2011). The immune response of 
GF mice is blunted: animals produce less of the proinflammatory 
cytokine tumor necrosis factor α after splenocyte stimulation with 
lipopolysaccharide (Clarke et al., 2013). Intriguingly, colonization of 
GF animals rescues mucosal immune system function (Umesaki 
et al., 1995). Together, these findings indicate that exposure to bac-
teria is necessary to mount a normal immune response.
Studies in GF mice have demonstrated that the gut bacteria 
are required for the normal function and structure of the GI sys-
tem. In GF mice, the cecum is enlarged, the intestinal surface area 
and number of villi are reduced, and Peyer’s patches are smaller 
and fewer (Wostmann and Bruckner-Kardoss, 1959; Gordon and 
Bruckner-Kardoss, 1961; Abrams et  al., 1962; Shanahan, 2002). 
Moreover, enterochromaffin cells, the cells that produce sero-
tonin in the GI tract (a key regulator of GI motility and secre-
tion), are larger in GF animals (Shanahan, 2002) although not 
greater in abundance (Reigstad et  al., 2015). Despite increases 
in cellular size, microbial metabolites dictate serotonin synthe-
sis, and lower levels of this neurotransmitter have been noted 
in GF animals (Reigstad et al., 2015; Yano et al., 2015). GF mice 
have a decreased rate of epithelial cell turnover in the intestine 
(Rakoff-Nahoum et al., 2004). This likely results in reduced pro-
tection against GI insults, since epithelial cell turnover promotes 
healing (Grenham et al., 2011). The intestine secretes antimicro-
bial factors in response to TLR activation (Vaishnava et al., 2008); 
therefore, the reduction of certain TLRs in GF animals may also 
render them more susceptible to infection by pathogenic bacte-
ria should they be exposed.
Metabolic and Digestive Function
The gut microbiota is involved in key metabolic processes. GF 
mice consume more food than control animals to maintain 
the same body weight (Wostmann et al., 1983). Moreover, GF 
mice remain resistant to diet-induced obesity even when they 
are fed a “Western” diet high in fat and sugar (Bäckhed et al., 
2004, 2007; Ding et al., 2010; Rabot et al., 2010). This propensity 
for leanness in GF mice is accompanied by increased levels of 
fatty acid oxidation enzymes, indicating that the microbiota 
is involved in host metabolism and energy storage (Bäckhed 
et al., 2007). It is important to note, however, that not all stud-
ies support that GF mice are protected against diet-induced 
obesity. Using a different strain of mice, Fleissner and col-
leagues (2010) confirmed that GF mice were resistant to the 
obesigenic effects of a Western diet but not of a low-sucrose, 
lard-based, high-fat diet. These findings indicate that diet 
composition and possibly genetic strain could influence the 
protection against diet-induced obesity afforded by the GF 
state (Shen et al., 2013).
The gut microbiota releases nutrients from otherwise una-
vailable oligosaccharides, modulates absorption, and synthe-
sizes essential nutrients (Sekirov et  al., 2010; Grenham et  al., 
2011).Therefore, it is unsurprising that the absence of micro-
biota also affects digestion. GF rodents have reduced production 
of short chain fatty acids, which are beneficial to host metabo-
lism and are produced when dietary fiber is fermented by bac-
teria (Høverstad and Midtvedt, 1986; den Besten et al., 2013). GF 
rats have deficient thiamine absorption: when these animals are 
fed radio-labeled thiamine, large quantities of the nutrient are 
found in the feces but little is found in the tissue (Wostmann 
et al., 1962). GF rats fed a diet without vitamin K rapidly become 
haemorrhagic and also require their diet to be supplemented 
with vitamin B to survive (Gustafsson, 1959b; Sumi et al., 1977). 
The gut microbiota is therefore required to synthesize vitamin K 
and B in the absence of these nutrients from the diet. To prevent 
Figure 1. Germ-free (GF) mice as a tool to study the microbiota-gut-brain axis. GF mice are raised in isolation in a GF unit without any exposure to microorganisms. 
Gut-brain signalling is altered due to the lack of bacterial exposure throughout the lifetime. The microbiota is required for normal stress responsivity, anxiety-like 
behaviors, sociability, and cognition. Furthermore, the microbiota protects CNS homeostasis by regulating immune function and blood brain barrier (BBB) integrity.
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nutritional deficiencies, the diet fed to GF mice is fortified with 
vitamins K and B (Grenham et al., 2011).
Enteric Nervous System Function
The changes that have been reported in CNS development and 
function in GF mice are reflected in the enteric nervous system 
(ENS), which is not surprising given that the cells found here 
are the first neural point of contact for commensal intestinal 
bacteria. Microbiota are necessary for the normal postnatal 
development of the enteric sensory and motor neurons, and at 
postnatal day 3, the structure, neurochemical composition, and 
function of enteric neurons in the jejunum and ileum of GF mice 
differ from controls (Collins et al., 2014). In the small intestine, 
GF mice have decreased overall nerve density, with fewer neu-
ronal cell bodies in myenteric ganglia and less connective nerve 
fibers between ganglia (Collins et al., 2014). The ganglia of intrin-
sic sensory neurons of the ENS are embedded in the gut wall 
(Forsythe and Kunze, 2013), and it has been established that the 
electrophysiological properties of these myenteric sensory neu-
rons, or afterhyperpolarization (AH) neurons, are altered in the 
absence of colonizing bacteria (Mcvey Neufeld et al., 2013; McVey 
Neufeld et al., 2015). Specifically, the AH period of the AH cells, 
during which the neuron is refractory to further firing, is elon-
gated in GF mice when compared with both controls and adult 
conventionalized GF mice. In other words, the gut sensory neu-
rons are less excitable under GF conditions. These same neurons 
are responsive to feeding of the probiotic Lactobacillus rhamonus 
(JB-1) in healthy rats, showing an increase in excitability after 
treatment (Kunze et al., 2009). Interestingly, GF rats have altered 
intestinal motility (Husebye et  al., 1994, 2001), and these sen-
sory neurons synapse on enteric motor neurons controlling gut 
motility, so this may provide a potential mechanistic explana-
tion for the dysfunction. The AH sensory neurons also synapse, 
both anatomically and functionally, with vagal nerve endings 
in the gut (Powley et  al., 2008; Perez-Burgos et  al., 2014) and 
thus could represent a direct neural route whereby the intesti-
nal bacterial status is transmitted to the brain. This hypothesis 
is consistent with the findings of alterations in extracellular 
recordings from mixed vagal and spinal nerve afferents in GF 
mice compared with both control and adult conventionalized GF 
animals (McVey Neufeld et al., 2015).
Stress Responsivity and Anxiety-Like Behavior
There is now a growing body of literature supporting the role 
of the gut microbiota in the regulation and development of 
the stress response system (Rhee et  al., 2009; Collins et  al., 
2012; Dinan and Cryan, 2012; Foster and McVey Neufeld, 2013; 
Sampson and Mazmanian, 2015). Signals from the gut are well 
known to activate the HPA axis: both infection by pathogenic 
bacteria and stimulation of the vagus nerve elicit corticosterone 
release (Hosoi et al., 2000; Zimomra et al., 2011). Altered microbi-
ota-brain-gut signalling is thought to play a role in the pathogen-
esis of GI disorders; patients with IBS have both an altered gut 
microbiota composition and irregular HPA axis activity (Jeffery 
et al., 2012; Kennedy et al., 2014a, 2014c). However, the evidence 
relating abnormal gut function to maladaptive responses to 
stressors is limited as of yet. Most of what is currently known 
about the regulation of stress responsivity by the gut microbiota 
has been discovered from preclinical rodent models.
Hypothalamic-Pituitary-Adrenal Axis Responsivity
Studies in GF mice have revealed that the microbiota influ-
ences the development of the HPA axis. The landmark study 
by Sudo et  al. (2004) was the first to demonstrate that acute 
restraint stress induces an exaggerated release of corticoster-
one in GF mice compared with specific pathogen-free controls 
(SPF; mice guaranteed to not harbor certain pathogens). This 
HPA axis hyperactivity is completely normalized when GF mice 
are monocolonized with Bifidobacterium infantis in the neonate 
period (Sudo et al., 2004). However, monocolonization with the 
enteropathogenic bacteria Escherichia coli induces even higher 
stress hormone release in GF mice. These contrasting find-
ings indicate that there are bacterial strain-specific effects on 
stress responsivity. Intriguingly, stress-induced corticosterone 
release is partially normalized by bacterial colonization occur-
ring at 6 but not at 8 weeks (Sudo et al., 2004), demonstrating 
that there is a critical window prior to adolescence during 
which the brain is sensitive to signals from the gut required 
for the normal development of the HPA axis. Increased stress-
induced corticosterone release has also been reported in GF 
rats (Crumeyrolle-Arias et  al., 2014). There is conflicting evi-
dence as to whether basal corticosterone levels are altered in 
GF mice: both increased (Neufeld et al., 2011) and normal (Sudo 
et al., 2004; Clarke et al., 2013) levels have been documented. 
These contrasting findings are likely due to fact that the strain, 
sex, mode of euthanasia, and acclimatization period differs 
between studies.
Stress Circuitry
Although it is now clear that microbiota-gut-brain signalling is 
involved in programming stress responsivity, little as of yet is 
known about the underlying neural circuitry. To determine if the 
normalization of HPA axis signalling occurs through an immu-
nological or neural route, Sudo and colleagues (2004) colonized 
GF mice with B. infantis at 5 weeks of age and measured cytokine 
release and activation of the paraventricular nucleus (PVN) of 
the hypothalamus. Inoculation with B. infantis induces corticos-
terone release and activates the PVN, as quantified by a marker 
for neuronal activation (c-Fos). Inoculation also induced the 
release of the proinflammatory cytokine interleukin-6. However, 
this effect seems to be independent of stress hormone release, 
since pretreatment with an anti-interleukin-6 antibody fails to 
affect corticosterone levels or activate the PVN. Taken together, 
these results suggest that stress-relevant signals from the gut 
microbiota are relayed to the brain through a neuronal, humoral 
cytokine-independent pathway.
Anxiety-Like Behavior
The logical question arising from the discovery of HPA axis 
hyperactivity in GF mice was if stress-related behaviors were 
also under the influence of the microbiota. A number of inde-
pendent laboratories have shown that GF mice exhibit a reduc-
tion in basal levels of anxiety-like behavior (Heijtz et al., 2011; 
Neufeld et  al., 2011; Clarke et  al., 2013; Arentsen et  al., 2015). 
However, it is also worth noting that some studies report no 
change in anxiety-like behavior in GF mice (Bercik et al., 2011a; 
Gareau et al., 2011). The stress-related behavioral profile of GF 
mice appears to be amenable to microbial intervention: the col-
onization of GF mice normalizes anxiety-like behavior (Clarke 
et  al., 2013). Curiously and perhaps more consistent with the 
exaggerated stress response, GF status in rats is anxiogenic, 
suggesting that growing up GF has a species-specific directional 
effect on anxiety levels (Crumeyrolle-Arias et al., 2014). Finally, 
the gut microbiota is required for the induction of the anxiogenic 
profile associated with early-life stress: unlike in conventionally 
colonized mice, anxiety-like behavior of GF mice is unaffected 
by maternal separation (De Palma et al., 2015).
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One of the principle advantages of the GF model is that it 
allows the researcher to colonize mice with bacteria and study 
the effects on host physiology and behavior. The transfer of 
microbiota from the high anxiety-like Balb/C mouse strain to 
low anxiety-like GF NIH Swiss mice is anxiogenic in the recipi-
ent (Belzung and Griebel, 2001; O’Mahony et  al., 2010; Bercik 
et  al., 2011a). The same is true of the reverse transplanta-
tion: NIH Swiss bacteria transferred into GF Balb/C attenuate 
the recipients’ anxious phenotype (Bercik et  al., 2011a). These 
results suggest that the composition of the gut microbiota may 
contribute to the behavioral and physiological aspects of GI dis-
orders. For example, patients with IBS display exaggerated HPA 
axis responses to an acute stressor, an altered composition of 
gut microbiota, and a high psychiatric comorbidity most com-
monly with mood disorders (Fond et  al., 2014; Kennedy et  al., 
2014b, 2014c). Targeting the microbiota with interventions such 
as probiotics could therefore improve both the GI and psychiat-
ric symptoms of IBS and related psychosomatic illnesses (Clarke 
et al., 2012). Furthermore, given that microbial transfer can alter 
stress responsivity, fecal microbiota transplantation may be a 
viable therapy for disorders for the microbiota-brain-gut axis 
(Borody and Khoruts, 2012; Aroniadis and Brandt, 2013). This is 
currently an active area of research, but it remains to be seen if 
the high success rates for those with recurrent Clostridium dif-
ficile infection will also be reflected in more complex and hetero-
geneous GI disorders.
Sociability, Self-Grooming, and Locomotion
Living among groups affords an evolutionary advantage, pro-
viding mutual protection, sharing of food, and more oppor-
tunities to mate (Hamilton, 1964; Stilling et  al., 2014a). It is 
therefore logical that the brain has evolved to foster social 
interaction. Microbes are contagious; they can spread to new 
hosts and environments through active or passive interac-
tions. This trait has led scientists to hypothesize that natu-
ral selection has favored bacterial species that can maximize 
their own transmission, including during host social inter-
action (Troyer, 1984; Lombardo, 2008; Ezenwa et  al., 2012; 
Montiel-Castro et al., 2013; Tung et al., 2015). The exchange of 
microbes between conspecifics is also advantageous for the 
host: symbiotic bacteria can protect against pathogenic infec-
tion and assist in digestion and nutrient absorption (Troyer, 
1984; Lombardo, 2008; Stilling et  al., 2014a). It can thus be 
hypothesized that both sociability and bacteria have had pro-
found and convergent influences on the evolution of brain and 
behavior.
Sociability
Our group has investigated the interaction between the micro-
biota and social behavior (Desbonnet et al., 2014). Under normal 
conditions, mice will seek out social situations that are novel 
and stable. However, in the 3-chambered sociability test, GF mice 
spend more time exploring an empty chamber than a chamber 
containing a mouse (social preference). In addition, GF mice 
do not display the expected partiality for a novel over a famil-
iar mouse (social cognition). Both social deficits are more pro-
nounced in male GF mice. The postweaning colonization of GF 
mice successfully reverses the impairment in social preference 
but not social cognition; colonized GF mice prefer the cham-
ber containing a mouse but display no preference for a novel 
compared with a familiar mouse. Taken together, this study 
demonstrates that microbes are required for normal sociabil-
ity. Moreover, it shows that social cognition is permanently 
developed by the preweaning period; however, the critical win-
dow during which social preference is susceptible to microbial-
based interventions appears to be longer.
In contrast to the results described above, a recent study 
by Arentsen and colleagues (2015) found that GF mice display 
increased social preference. The reason for these conflicting 
findings is unclear: the mouse strain, sex, and 3-chambered 
sociability test protocol were the same between studies. The 
authors propose that differences in the age of the GF mice and 
in the strain of novel mouse may account for the contrasting 
results. Moreover, the control SPF mice used by Arentsen et al. 
(2015) were housed in isolators, whereas the control mice used 
by Desbonnet et al. (2014) were not. The marked hyperactivity 
responses seen in the Arenston et al. (2015) study may also play 
a role. Regardless of the disparity between these results, the 2 
studies are in agreement that a gut microbiota is required for 
normal social behavior in mice.
Self-Grooming and Locomotion
In addition to the observed deficits in sociability, male GF mice 
engage in more stereotyped, repetitive self-grooming behaviors 
compared with controls (Desbonnet et al., 2014). These animals 
also display increased locomotor activity and rearing (Heijtz 
et al., 2011). However, there are no locomotor changes in female 
GF mice (Neufeld et al., 2011). Where such changes have been 
noted, postweaning colonization normalizes abnormal self-
grooming, locomotion, and rearing in GF mice (Heijtz et al., 2011; 
Desbonnet et al., 2014). These results indicate that the micro-
biota influences the neural networks controlling stereotyped, 
repetitive, and locomotor behaviors.
The Germ-Free Mouse: Parallels to Autism Spectrum Disorder
The observed alterations in sociability, locomotor activity, and 
repetitive, stereotyped behaviors in GF mice have particular sig-
nificance for autism spectrum disorder (ASD). ASD is character-
ized by impaired sociability and communication and by frequent 
repetitive and stereotyped behaviors. Intriguingly, patients with 
ASD have an altered composition of the gut microbiota and 
commonly suffer from GI complications such as constipation 
and increased intestinal permeability (Howard et al., 2000; Kang 
et al., 2013; Mulle et al., 2013; Mayer et al., 2014; Rosenfeld, 2015; 
Sampson and Mazmanian, 2015). Furthermore, there is a higher 
prevalence of inflammatory bowel disease and GI illnesses in 
individuals with ASD (Kohane et al., 2012). Taken together, these 
findings implicate the microbiota in the pathogenesis of this 
neurodevelopmental disorder.
Interestingly, the behavioral and physiological profile of 
rodent models of ASD is comparable with that of GF mice. 
Maternal immune activation in mice reduces sociability and 
heightens both anxiety-like and stereotyped behaviors of the 
offspring (Hsiao et al., 2013). These animals also have deficient 
intestinal integrity and an altered composition of gut microbiota 
(Hsiao et al., 2013). Importantly, many of these behavioral and 
GI impairments in mice exposed to maternal immune activa-
tion can be ameliorated by administering B. fragilis (Hsiao et al., 
2013). These behavioral and GI deficits have also been noted in 
another mouse model of autism: mice exposed to valproate in 
utero show both impaired sociability and an altered gut micro-
biome (de Theije et al., 2014). If the hypothesis that ASD has a 
microbial etiology proves correct, interventions targeting the gut 
microbiota such as diet and pro- and pre-biotics could provide 
safe and effective strategies for targeting neurodevelopmen-
tal disorders and their associated comorbidities (Gilbert et al., 
2013; Mayer et al., 2014; Sampson and Mazmanian, 2015). ASD 
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is of course too complex to be completely recapitulated in any 
one animal model (Mayer et al., 2014). These provocative results 
need to be integrated with the current genetic and environmen-
tal factors associated with the development of autistic behavior 
(Fakhoury, 2015). Interestingly, the early-life microbial disrup-
tion induced by Caesarean section delivery is associated with 
an only modestly increased ASD risk in epidemiological studies 
(Curran et al., 2015b) that may in fact be due to due to familial 
confounding (Curran et al., 2015a). Nevertheless, the preclinical 
data do suggest the potential of using microbial-based interven-
tions to improve many of the prominent abnormal behaviors in 
ASD.
Learning and Memory
Given that the gut microbiota has pronounced effects on socia-
bility and stress responsivity, it is perhaps unsurprising that 
it also regulates cognitive ability. Treatment of mice with a 
potential Lactobacillus probiotic improves memory (Savignac 
et al., 2015). This bacteria-induced memory enhancement may 
be due to changes in hippocampal activity: probiotic treatment 
prevents age-associated impairments in long-term potentia-
tion in the rat hippocampus (Distrutti et al., 2014). In contrast, 
exposure to the enteric pathogen Citrobacter rodentium induces 
memory deficits in stressed mice (Gareau et al., 2011). To fur-
ther explore the idea that the gut microbiota can influence cog-
nition, Gareau and colleagues (2011) tested the learning and 
memory abilities of GF mice. To assess dorsal hippocampus-
mediated memory, mice underwent a one-trial version of the 
novel object test that compares the frequency of exploration 
of a familiar vs a novel object between groups (Ennaceur and 
Delacour, 1988). In addition, the ability of mice to remember 
a familiar environment was tested using the T-maze test. In 
this test, memory is assessed by comparing left vs right arm 
entries, with an equal amount indicating the mice remember 
which arm they have previously explored. This study revealed 
that a gut microbiota is required for normal cognition, as GF 
mice spend less time exploring novel objects and environ-
ments compared with controls. However, olfactory memory in 
GF mice appears to be normal (Desbonnet et al., 2014). GF mice 
have less c-Fos-positive CA1 hippocampal cells after undergo-
ing memory testing, indicating that these cognitive impair-
ments may be due to a reduction in hippocampal activity. 
Together, this study indicates the absence of a gut microbiota 
impairs spatial and object, but not olfactory, memory abilities, 
possibly through altered hippocampal signalling tone. This is 
consistent with the molecular and neurochemical changes 
that have been noted in this important brain region in GF ani-
mals (see below).
Molecular and Neurochemical Changes in the  
Germ-Free Brain
Although studies of GF mice clearly demonstrate that the gut 
microbiota influences stress responsivity, sociability, and cog-
nition, the molecular and neurochemical correlates of these 
effects remain largely unknown. Here, we summarize what 
is presently known about the microbial regulation of neuro-
transmission, neurotrophic factors, and synapse-related gene 
expression.
Serotonin
The neurotransmitter serotonin (5-hydroxytryptamine) regu-
lates mood, appetite, sleep, and cognition (Wrase et al., 2006). 
Although it is principally known for its role in the CNS, approxi-
mately 95% of the body’s serotonin is found in the GI system, 
where it mediates pain perception and gut secretion and motil-
ity (Ridaura and Belkaid, 2015; Yano et al., 2015). Given the high 
comorbidity of GI and mood disorders, it makes sense that drugs 
targeting the serotonergic system effectively treat the symp-
toms of IBS and anxiety and depressive disorders (O’Mahony 
et al., 2015).
Tryptophan is an essential amino acid and a precursor for 
serotonin. Reduction in tryptophan levels results in deficient 
serotonin production and depressive-like symptoms (Myint 
et  al., 2007). The gut microbiota is required for the normal 
breakdown and absorption of nutrients, which raises the pos-
sibility that both tryptophan levels and serotonergic signalling 
are altered in GF mice. Indeed, GF mice have elevated levels of 
plasma tryptophan compared with controls (Clarke et al., 2013). 
Increased hippocampal levels of serotonin are also found in 
male, but not female, GF mice. Importantly, colonization with 
bacteria postweaning normalizes tryptophan availability but 
not hippocampal serotonin levels (Clarke et al., 2013). Together, 
these findings indicate that the microbiota affects serotonergic 
signalling in the CNS, perhaps by altering peripheral tryptophan 
availability. Subsequent studies also suggest a degree of tem-
poral specificity in this regulatory role (El Aidy et al., 2012). ENS 
serotonergic levels are also affected by microbial metabolites 
such as short-chain fatty acids (SCFAs) (Reigstad et  al., 2015; 
Yano et al., 2015). Thus, serotonergic signalling in the “second 
brain” is also contingent on an intact gut microbiome (Ridaura 
and Belkaid, 2015). Since circulating serotonin levels are largely 
drawn from GI sources, this tallies with studies showing lower 
serum levels of serotonin in GF animals (Ridaura and Belkaid, 
2015) and has implications beyond the gut given the expansive 
biology of serotonin (Berger et al., 2009).
Brain Derived Neurotrophic Factor
Brain derived neurotrophic factor (BDNF) promotes the growth 
and development of new neurons and the survival of exist-
ing neurons (Park and Poo, 2013). Altered levels of BDNF in the 
CNS are well known to be associated with affective disorders in 
humans (Autry and Monteggia, 2012). In GF mice, Bdnf expres-
sion is lower in the cortex and amygdala compared with con-
trols (Heijtz et  al., 2011). In the hippocampus, the changes in 
Bdnf levels documented are inconsistent: studies report both 
an increase (Neufeld et al., 2011) and a decrease in expression 
(Sudo et al., 2004; Gareau et al., 2011; Heijtz et al., 2011; Clarke 
et  al., 2013). What is evident from these findings is that the 
microbiota influences BDNF expression in the CNS. How these 
microbiota-induced changes in neurotrophin factor expression 
affect the structure and function of the GF brain warrants fur-
ther investigation.
Synapse-Related Transcriptome
Evidence that the microbiota acts on the brain at a synaptic level 
stems from differing expression of mRNA and proteins in GF vs 
control mice. In GF mice, the dopamine receptor subunit Drd1a is 
increased in the hippocampus (Heijtz et al., 2011). Moreover, the 
glutamate receptor subunit Nr1 is decreased in the cortex while 
Nr2 is reduced in the cortex, hippocampus, and central nucleus 
of the amygdala (Sudo et al., 2004; Neufeld et al., 2011). In the 
striatum, expression of the synaptic proteins synaptophysin and 
postsynaptic density protein-95 (PSD-95) is elevated (Heijtz et al., 
2011). Our group has recently published data demonstrating that 
genes involved in neuronal activity are upregulated in GF mice, 
indicating potential amygdalar hyperactivity in these animals 
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(Stilling et al., 2015). Although further experiments are required 
to fully understand how the microbiota regulates synaptic trans-
mission and morphology, these results clearly indicate that brain 
regions important for sociability, stress responsivity, and cogni-
tion are altered on a synaptic level in GF mice.
Neurogenesis
Neurogenesis, the generation of new neurons, is a key process 
involved in memory formation, stress responsivity, and antide-
pressant treatment efficacy (Snyder et  al., 2011; Marín-Burgin 
and Schinder, 2012; Miller and Hen, 2015). That anxiety-like 
behavior, HPA axis signalling, neurotrophic factor expression, 
and learning and memory differ in GF mice led us to hypoth-
esize that adult hippocampal neurogenesis could also be influ-
enced by the gut microbiota (Ogbonnaya et al., 2015). This study 
revealed that cell survival, but not proliferation, is increased in 
the subgranular zone of the hippocampus. Likewise, the sur-
vival of newly born neurons is increased in GF mice primarily 
in the dorsal hippocampus, a subregion preferentially involved 
in spatial memory (Moser et al., 1995; O’Leary and Cryan, 2014). 
This change in adult neurogenesis could therefore underlie the 
deficits in spatial learning and memory of GF mice. However, it 
is worth remarking that increased hippocampal neurogenesis is 
typically associated with improved cognitive ability (Deng et al., 
2010). Postweaning colonization does not normalize any of the 
changes in cell and neuron survival, indicating that there may 
be a critical window prior to weaning during which neurogen-
esis is amenable to microbial intervention.
Blood Brain Barrier
The blood brain barrier (BBB) filters the passage of water-soluble 
molecules from the blood to the brain. The BBB is formed early 
in fetal life to protect the fetus against harmful toxins and bac-
teria during this sensitive period of brain development (Ballabh 
et al., 2004; Knudsen, 2004; Abbott et al., 2010). Disruption of the 
BBB can expose the CNS to damage and disease (Ballabh et al., 
2004; Abbott et al., 2010). Understanding how the gut microbiota 
and its circulating metabolites affect the BBB may inform new 
strategies to prevent and treat BBB-associated neuropsychiatric 
disorders (Kelly et al., 2015).
To answer this question, Braniste et al. (2014) examined BBB 
development and function in GF mice. In fetal mice from SPF 
dams, the BBB prevents the penetration of labelled immuno-
globulin; however, the BBB of fetal mice from GF dams allows 
the immunoglobulin to diffuse into the brain. As adults, the BBB 
of GF mice continues to be more permeable than that of their 
SPF counterparts. The authors propose that these changes in 
barrier function are due to tight junction abnormalities. Indeed, 
tight junction protein expression is reduced in both fetal and 
adult GF mice. Moreover, tight junctions in the brains of GF mice 
appear diffuse and disorganized. Colonization of adult GF mice 
with microbiota from SPF mice successfully reduces BBB per-
meability and increases tight junction protein expression. The 
effects of colonization on the BBB are likely mediated by SCFAs 
or metabolites produced by gut bacteria: monocolonization 
with a butyrate-producing bacterial strain or sodium butyrate 
administration alone decreases BBB permeability and increases 
tight junction expression. This study highlights the importance 
of the microbiota in BBB development: increased diffusion of 
molecules into the growing brain could affect neural connec-
tivity and underlie the maladaptive behavioral and physiologi-
cal profile of GF mice. More research is needed to determine if 
microbiota-directed interventions such as probiotics or dietary 
changes could effectively target BBB-related disorders and their 
associated comorbidities.
Microglia
Microglia are the resident macrophages of the CNS and act 
as the first line of immune protection for the brain and spi-
nal cord. By scavenging infectious agents, damaged cells, and 
other potential toxins, these cells maintain CNS homeosta-
sis (Ransohoff and Perry, 2009; Kettenmann et  al., 2011; Prinz 
and Priller, 2014). Microglia are also involved in shaping neu-
ral circuits in the developing brain (Schafer and Stevens, 2013). 
A growing number of studies have associated microglia-related 
genes with neuropsychiatric disorders such as Alzheimer’s dis-
ease (AD) and dementia (Prinz and Priller, 2014), illnesses now 
termed microgliopathies.
Although the gut microbiota has long been known to impact 
the peripheral immune system, little was known until recently 
regarding its modulation of immune development and function 
in the CNS (Cryan and Dinan, 2015). To investigate the relation-
ship between the microbiota and CNS immune function, Erny 
and colleagues (2015) studied the homeostasis and maturation 
of microglia in GF mice. Initial experiments revealed marked 
differences in mRNA expression profiles of microglial genes in 
GF mice. Further analyses confirmed that GF mice have more 
microglia throughout the entire brain compared with controls. 
The microglia of GF mice also have an abnormal morphology: 
processes are longer, more complex, and frequently overlap 
with other cells. In response to bacterial or viral challenge, pro-
inflammatory gene expression is attenuated and microglia do 
not display an activated morphology in GF mice, indicating that 
a microbiota is required to mount an appropriate response to 
pathogenic infection in both the periphery and the CNS.
The above findings raise the possibility that microglia could 
require constant input from the host microbiota to maintain CNS 
homeostasis. To answer this question, Erny et al. (2015) investi-
gated the effect of antibiotic-induced microbiota depletion on 
microglia of adult mice. Antibiotic-treated SPF mice exhibit an 
immature microglial profile similar to that of GF mice. Unlike GF 
mice, however, antibiotic treatment does not affect the number 
of microglia in the brain. Furthermore, it appears that a full rep-
ertoire of commensal microorganisms is necessary for normal 
microglial homeostasis: colonization with a complex composi-
tion of bacteria, but not a 3-strain Schaedler flora (select strains 
found in the normal mouse microbiota), normalizes microglial 
function and morphology in GF mice. Importantly, administra-
tion of SCFAs to GF mice almost completely restores microglia 
density, morphology, and maturity. This study elegantly dem-
onstrates that SCFA signalling from a complex bacterial com-
munity is required for the normal structure and homeostatic 
function of the CNS immune system.
Neurological Disorders
To date, GF research has largely focused on the psychiatric disor-
ders; however, there is now preliminary evidence that GF mice can 
also be useful tools in the study of neurological disorders. Recent 
studies have demonstrated that a GF state imparts a resistance to 
traits associated with multiple sclerosis (MS) and AD.
Multiple Sclerosis
MS is an autoimmune disease affecting myelin, the protective 
sheath that surrounds neurons of the CNS (Goverman, 2009; 
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Mielcarz and Kasper, 2015). This damage can cause physical, 
cognitive, and sometimes psychiatric symptoms. The progres-
sion of MS likely involves both genetic and environmental fac-
tors (Becker et al., 1998; Willer et al., 2003; Dendrou et al., 2015). 
Recent studies have suggested that altered microbial stimula-
tion of the immune system could be an environmental com-
ponent of MS (Dendrou et al., 2015; Mielcarz and Kasper, 2015). 
Intriguingly, some microorganisms seem to potentiate MS in 
humans, while others have preventative effects (Ascherio, 
2013).
The experimental autoimmune encephalomyelitis (EAE) ani-
mal model reproduces many of the characteristics of MS and is 
induced through immunization with CNS antigens in the pres-
ence of bacterial adjuvants (Stromnes and Goverman, 2006). 
When SPF mice are immunized with myelin oligodendrocyte 
glycoprotein peptides in complete Freund’s adjuvant, all ani-
mals develop signs of disease (Berer et al., 2011; Lee et al., 2011). 
Remarkably, GF are highly resistant to (Lee et al., 2011) or do not 
develop EAE at all (Berer et al., 2011). However, EAE responsiv-
ity is restored when GF mice are colonized with only segmented 
filamentous bacteria (Lee et al., 2011) or commensal microbiota 
from SPF mice (Berer et al., 2011). The absence of EAE in GF mice 
could be due to an altered balance in pro- and anti-inflammatory 
immune responses: GF mice produce lower levels of proinflam-
matory cytokines and anti-myelin oligodendrocyte glycoprotein 
autoantibodies, but higher levels of regulatory T cells (Berer et al., 
2011; Lee et al., 2011). Taken together, these findings suggest that 
the modulation of the gut microbiota could represent novel ther-
apeutic targets for inflammatory diseases such as MS.
Alzheimer’s Disease
AD is a chronic neurodegenerative illness and the most common 
cause of dementia in the Western world (Burns and Iliffe, 2009). 
The amyloid hypothesis posits that extracellular deposition of 
amyloid beta (Aβ) peptides triggers a cascade of pathological 
events, eventually leading to dementia (Hardy and Higgins, 1992; 
Ittner and Götz, 2011; Musiek and Holtzman, 2015). Although it 
is known that the composition of the gut microbiota changes as 
we age, the role of these microbes in the pathogenesis of age-
related disorders such as AD remains to be explored (O’Toole 
and Claesson, 2010). To investigate a possible link with the gut 
microbiota, Harach and colleagues (2015) studied the amyloid 
deposition in transgenic AD mice raised GF. When raised with 
commensal microbiota, APPPS1 transgenic mice exhibit an 
age-dependent accumulation of Aβ plaques in the brain (Radde 
et al., 2006). In contrast, GF APPPS1 mice accumulate far less Aβ 
plaques in the CNS (Harach et al., 2015). This decrease in Aβ is 
accompanied by an increase in Aβ-degrading enzymes and a 
reduction in neuroinflammation, as measured by the microglial 
marker Iba-1 (Harach et  al., 2015). Interestingly, the microbial 
composition of conventionally colonized APPPS1 mice differs 
from that of wild-type mice (Harach et al., 2015). Furthermore, 
only the transfer of microbiota from APPPS1 and not wild-type 
mice can effectively increase CNS Aβ levels in GF APPPS1 mice 
(Harach et al., 2015). These findings suggest that the gut micro-
biota may be involved in the development of AD pathology, and 
further experiments in this field are warranted.
Strengths, Limitations, and Alternatives to the 
Germ-Free Mouse Model
As humans are never in a truly GF state—even prenatally as 
previously hypothesized (Funkhouser and Bordenstein, 2013)—
criticisms of the GF model usually revolve around its apparent 
lack of clinical relevance. It should be clear, however, that the 
use of GF animals in preclinical work is not to directly mimic 
the human condition. Arguably, we should instead focus on the 
strengths of the GF animals as models for understanding the 
role of bacteria on host development and function. Its artifi-
cially controlled state allows us to study the dysfunction aris-
ing in the absence of any microbial input on behavior, anatomy, 
and physiology. It also provides a clean background onto which 
we can add either a single strain of bacteria, such as in mono-
colonization, or a predefined cocktail of commensal microbiota. 
Conventionalizing GF mice in this manner allows us to deter-
mine the impact of specific bacteria on any number of health-
related issues. Vitally, bacteria can also be introduced to GF mice 
at various time points of host development, permitting us to 
examine the existence of critical windows of development that 
may require bacterial input. Indeed, this is currently an area 
of keen interest and the focus of many ongoing colonization 
experiments.
Given that GF animals have no bacterial exposure from 
conception onwards, they are perhaps of limited usefulness 
for experimental questions regarding the impact of altered 
microbiota composition that first occurs later in life. For these 
reasons, alternatives to the GF model must be explored that 
allow for alterations in bacterial exposure occurring through-
out the lifespan. Some alternatives do currently exist and are 
being used to complement GF findings, including those using 
antibiotic treatment, probiotic feeding, fecal transplantation, 
and mouse humanization, among others. Antibiotic treatment 
of mice is regarded as a practical and potentially more relevant 
alternative to the use of GF mice, and, interestingly, many of the 
phenotypic features associated with the GF state (eg, reduced 
anxiety-like behaviors) are also evident after a sustained anti-
biotic-induced disruption of the gut microbiota. A recent study 
examining the long-term effects of antibiotic treatment and the 
resulting altered intestinal microbial composition focused on 
the critical developmental window of adolescence (Desbonnet 
et al., 2015). Here, treating mice with a combination of antibiot-
ics resulted in reduced anxiety, reduced cognitive abilities, and 
social deficits. In addition, antibiotic-treated mice also displayed 
reduced levels of BDNF, oxytocin, and vasopressin in adult brain 
tissue (Desbonnet et al., 2015). Alterations to tryptophan met-
abolic pathways were also observed (Desbonnet et  al., 2015). 
Earlier work involving administration of an antibiotic cocktail 
of bacitracin and neomycin as well as the anti-fungal prima-
ricin to mice has demonstrated reduced anxiety-like behavior 
and increased hippocampal BDNF mRNA expression (Bercik 
et  al., 2011a) as well as increased visceral sensitivity to colo-
rectal distension tests that can be ameliorated after probiotic 
administration (Verdu et al., 2006). Researchers have also inves-
tigated the effects of introducing bacteria to mouse models of 
intestinal dysbiosis. Humanization studies can involve human 
fecal transfer to GF mice but have recently been broadened to 
include inoculating non-GF antibiotic-treated mice with human 
feces (Hintze et al., 2014). Mice treated in this fashion are not 
only useful in examining microbiota-gut-brain communica-
tion but provide a more clinically relevant model in which to 
ask questions regarding the effects of differing bacterial com-
munities on the host. GF animals have been vital in helping us 
elucidate mechanisms of gut-brain communication, as well as 
the role of commensal microbiota in development and function 
of the organism. However, moving forward, alternatives to GF 
animals such as those elucidated above will provide us with a 
complementary understanding in a more obviously clinically 
relevant manner.
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Conclusion
From the inception of studies using GF animals to today, we 
have garnered a significant body of knowledge with respect 
to bacterial-host communication in wellness and disease. 
Through the examination of GF animals both before and after 
introduction of bacteria, whether single-strain or as a bacterial 
community, we now know that host-bacterial communication 
is necessary for the optimal function of virtually all physiologi-
cal processes in the organism. Bacteria are necessary for the 
healthy functioning of the immune, respiratory, GI, metabolic, 
endocrine, and nervous systems of the organism, and this has 
led many researchers to now consider humans (and most other 
organisms) as holistic functioning units working together with 
their bacterial counterparts. Moving forward, experiments 
using a variety of approaches to manipulate intestinal bacteria 
will be used to complement those carried out in the GF model 
and will provide us with a better understanding of the com-
munication that occurs between the host and its bacterial resi-
dents, as well as how this communication works to improve 
overall health.
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